Edition:
United States

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.46USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.46
Open
$1.46
Day's High
$1.50
Day's Low
$1.46
Volume
5,722
Avg. Vol
40,396
52-wk High
$6.15
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.175
Sep '17 0.00 -0.907
Jun '17 0.00 -0.504
Mar '17 0.00 -0.376
FY 2016 Dec '16 0.28 -0.678
Sep '16 0.20 -0.862
Jun '16 0.22 -1.005
Mar '16 0.14 -1.042
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 2.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.10 -0.10 -0.10 --
Quarter Ending Sep-18 1 -0.09 -0.09 -0.09 --
Year Ending Dec-18 1 -0.41 -0.41 -0.41 -1.57
Year Ending Dec-19 1 -0.32 -0.32 -0.32 -1.18
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 200.91 33.50
P/E High - Last 5 Yrs. -- 289.20 46.07
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta 3.63 0.75 0.80
Price to Sales (TTM) -- 139.09 7.25
Price to Book (MRQ) 0.80 20.64 5.09
Price to Tangible Book (MRQ) 0.80 25.50 6.62
Price to Cash Flow (TTM) -- 130.26 25.50
% Owned Institutions 6.33 11.26 2.24

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.97 3.92
Payout Ratio(TTM) -- 9.05 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 81.71 8.68
Sales (TTM) vs TTM 1 Yr. Ago -100.00 96.34 11.19
Sales - 5 Yr. Growth Rate -- 34.26 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 74.20 -64.57 22.73
EPS (TTM) vs TTM 1 Yr. Ago 45.32 -- --
EPS - 5 Yr. Growth Rate -- 48.47 10.28
Capital Spending - 5 Yr. Growth Rate 1.61 45.82 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.53
Current Ratio (MRQ) 6.32 6.04 3.61
LT Debt to Equity (MRQ) 0.00 23.33 11.39
Total Debt to Equity (MRQ) 0.00 25.72 14.02
Interest Coverage (TTM) -- -190.60 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 35.01 54.05
Gross Margin - 5 Yr. Avg. -- 55.51 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,420.21 -150.51 15.90
Operating Margin (TTM) -- -562.45 4.09
Operating Margin - 5 Yr. Avg. -1,431.26 -162.33 11.23
Pre-Tax Margin (TTM) -- -534.74 4.81
Pre-Tax Margin - 5 Yr. Avg. -1,306.91 -168.92 11.54
Net Profit Margin (TTM) -- -524.03 1.42
Net Profit Margin - 5 Yr. Avg. -1,127.90 -168.92 7.87
Effective Tax Rate (TTM) -- -0.15 30.96
Effective Tax Rate - 5 Yr. Avg. -- 18.29 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,331,705 813,295,447
Net Income/Employee (TTM) -622,500 1,121,504 95,590,786
Receivable Turnover (TTM) -- 6.53 5.56
Inventory Turnover (TTM) -- 2.32 3.44
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -32.72 -0.74 10.51
Return on Assets - 5 Yr. Avg. -47.89 0.80 11.54
Return on Investment (TTM) -41.16 -0.75 13.17
Return on Investment - 5 Yr. Avg. -63.52 4.16 14.94
Return on Equity (TTM) -82.38 -2.86 14.98
Return on Equity - 5 Yr. Avg. -81.57 -0.19 16.23
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 44.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cyclacel Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.33%
# of Holders: 16
Total Shares Held: 758,944
3 Mo. Net Change: -2,000
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.